Biology, AI & what comes next: Founder Mixer

​Join us for an evening of conversation at the intersection of biology and artificial intelligence, hosted at Arkam Ventures. If you are building in biotech, computational biology, AI-driven drug discovery, synthetic biology, or anywhere in the space where biology meets software, this is a good room to be in.

Format:
2 moderated panels + Q&A, followed by dinner and open conversation

​The Conversations:

​Panel 1 — AI in Bio
Moderated by Yash Jain, Sparrow Capital

​Ajitesh Lunge, Co-founder & CEO, Locksmith Bio
Locksmith Bio uses physics-based AI to map intrinsically disordered proteins and open up drug targets previously considered undruggable. The conversation will cover where AI is actually delivering in drug discovery today, the data and validation challenges, and what it takes to build a credible AI-first bio company from Bangalore.

​

​Panel 2 — AI in Medtech
Moderated by Sridhar Ramanathan, IKP

​Reuben Fernandes, Co-founder & CEO, Atom360
Atom360's Berry.care uses AI for early oral cancer detection on a smartphone, making accurate screening accessible without specialist infrastructure.

​Dr. Anchal Chandra, Co-founder & CEO, BioLOCKEY
BioLOCKEY's NANOdx platform uses yeast surface display and high-throughput screening to rapidly discover Nanobodies against virtually any target. The conversation will go into GTM in clinical environments, defensibility, and what AI regulation in medtech looks like before it hardens.

​
Space is limited to 40 attendees. 

​The Biotech Edition is a chapter of the Arkam Terrace Series, a rooftop format we run for focused conversations at the frontier of technology. This edition is co-hosted with Sparrow Capital and IKP